Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Planning and Dissemination Grant - Institute Community Support

University of Alberta

$15,000.00

Canadian Cardiovascular Research Collaboratory (C3) General Meeting

FY 2022-23

Summary
The Canadian Cardiovascular Research Collaboratory (C3) was established in 2017, based in part upon the support from a CIHR-Institute for Community Support in partnership with the Institute for Circulatory & Respiratory Health Planning and Dissemination Grant. Over the past 5 years, this virtual clinical cardiovascular (CV) research network has been supported in-kind without external funding by the CVC (Canadian Virtual Coordinating Centre for Global Collaborative Cardiovascular Research (VIGOUR) Centre, University of Alberta) and the HSRLCE (Heart & Stroke Richard Lewar Centre of Excellence, University of Toronto). The C3 blends 2 fundamental elements--"collaboration" and the clinical research "laboratory"-to provide novel opportunities for collaborative CV researchers to identify and study important unanswered questions. Indeed, an unmet need exists to strengthen synergies among Canadian researchers to expedite the discovery, evaluation, and application of observational and clinical trial studies, and the application of emergent therapies and strategies for CV disease (CVD). Given a small critical mass of CVD researchers who are widely spread across the country and vying for limited research funding, there is an imperative to share and combine efforts. We have therefore developed a network of >50 Canadian CVD researchers affiliated with university-based research centers committed to sustained and meaningful collaboration to enhance the prevention, diagnosis, and treatment of CVD. We are proposing a general, in-person meeting in June 2023 in order to: discuss and ratify suggested changes to the network's mission; identify concrete strategies for the equitable, diverse, and inclusive expansion of the membership; critically evaluate (direct peer-to-peer review) the progress of the Working Group clinical research projects; and disseminate the deliberations to the Canadian CV research community.
Program
Planning and Dissemination Grant - Institute Community Support
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
480716
Name
Goodman Shaun G
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Clinical
Prcname2
Planning and Dissemination Grants
Projecttitle
Canadian Cardiovascular Research Collaboratory (C3) General Meeting
Programtype2
Miscellaneous Programs
Orgnameinp2
University of Alberta
Cihramount2
$15,000
Cihrequipment2
$0
Programname2
Planning and Dissemination Grant - Institute Community Support
Keyworddelim
Cardiovascular Disease
Abstract
The Canadian Cardiovascular Research Collaboratory (C3) was established in 2017, based in part upon the support from a CIHR-Institute for Community Support in partnership with the Institute for Circulatory & Respiratory Health Planning and Dissemination Grant. Over the past 5 years, this virtual clinical cardiovascular (CV) research network has been supported in-kind without external funding by the CVC (Canadian Virtual Coordinating Centre for Global Collaborative Cardiovascular Research (VIGOUR) Centre, University of Alberta) and the HSRLCE (Heart & Stroke Richard Lewar Centre of Excellence, University of Toronto). The C3 blends 2 fundamental elements--"collaboration" and the clinical research "laboratory"-to provide novel opportunities for collaborative CV researchers to identify and study important unanswered questions. Indeed, an unmet need exists to strengthen synergies among Canadian researchers to expedite the discovery, evaluation, and application of observational and clinical trial studies, and the application of emergent therapies and strategies for CV disease (CVD). Given a small critical mass of CVD researchers who are widely spread across the country and vying for limited research funding, there is an imperative to share and combine efforts. We have therefore developed a network of >50 Canadian CVD researchers affiliated with university-based research centers committed to sustained and meaningful collaboration to enhance the prevention, diagnosis, and treatment of CVD. We are proposing a general, in-person meeting in June 2023 in order to: discuss and ratify suggested changes to the network's mission; identify concrete strategies for the equitable, diverse, and inclusive expansion of the membership; critically evaluate (direct peer-to-peer review) the progress of the Working Group clinical research projects; and disseminate the deliberations to the Canadian CV research community.
Competitiondate
202302
Approvedterm2
1 yr 0 mth
Pinamesdelim
Goodman, Shaun G
Approvedterm
1 an 0 mois
Cihrcontribution2
ICRH~ $15,000~ $0~